(LDOS) Leidos Holdings - Ratings and Ratios
Defense, Cybersecurity, Health, Aviation, Energy
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.88% |
| Yield on Cost 5y | 1.66% |
| Yield CAGR 5y | 3.16% |
| Payout Consistency | 92.8% |
| Payout Ratio | 14.1% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 26.4% |
| Value at Risk 5%th | 31.8% |
| Relative Tail Risk | -26.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.94 |
| Alpha | 19.11 |
| CAGR/Max DD | 0.61 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.479 |
| Beta | 0.453 |
| Beta Downside | 0.427 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.86% |
| Mean DD | 10.92% |
| Median DD | 7.48% |
Description: LDOS Leidos Holdings December 17, 2025
Leidos Holdings, Inc. (NYSE:LDOS) delivers a broad portfolio of technology and engineering services to government and commercial clients, organized into four primary segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. The National Security & Digital segment leverages AI/ML to integrate sea, ground, air, and space operations, offering cyber-defense, intelligence analysis, biometrics, and digital transformation services. The Health & Civil segment supports air-traffic control, health-mission software, managed health services, and life-science R&D. The Commercial & International segment focuses on grid modernization, airport security platforms, biometric border solutions, and inspection technologies. The Defense Systems segment provides airborne, missile-defense, maritime, aerospace, and cyber-threat systems.
Key financial and market indicators underscore Leidos’ growth trajectory: FY 2023 revenue reached approximately $12.4 billion, with an operating margin of 9.5% and a backlog of roughly $8.5 billion, reflecting strong multi-year contract pipelines. Federal defense spending is projected to rise 3-4% YoY, bolstering demand for Leidos’ cyber-security and AI-driven warfighter solutions, while the U.S. Department of Transportation’s $30 billion air-traffic modernization plan fuels the Health & Civil segment’s pipeline.
Leidos’ diversification across high-growth government IT, defense, and critical infrastructure markets positions it to benefit from sustained fiscal-year spending increases and the broader digital-transformation wave in the public sector.
For a deeper quantitative dive, you might explore LDOS’s metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (1.41b TTM) > 0 and > 6% of Revenue (6% = 1.04b TTM) |
| FCFTA 0.10 (>2.0%) and ΔFCFTA 0.35pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 10.75% (prev 5.42%; Δ 5.32pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.11 (>3.0%) and CFO 1.55b > Net Income 1.41b (YES >=105%, WARN >=100%) |
| Net Debt (4.25b) to EBITDA (2.35b) ratio: 1.81 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.62 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (130.1m) change vs 12m ago -2.88% (target <= -2.0% for YES) |
| Gross Margin 17.61% (prev 16.59%; Δ 1.03pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 129.0% (prev 122.0%; Δ 6.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 10.18 (EBITDA TTM 2.35b / Interest Expense TTM 202.0m) >= 6 (WARN >= 3) |
Altman Z'' 3.51
| (A) 0.14 = (Total Current Assets 4.85b - Total Current Liabilities 2.99b) / Total Assets 13.54b |
| (B) 0.32 = Retained Earnings (Balance) 4.38b / Total Assets 13.54b |
| (C) 0.15 = EBIT TTM 2.06b / Avg Total Assets 13.44b |
| (D) 0.50 = Book Value of Equity 4.32b / Total Liabilities 8.59b |
| Total Rating: 3.51 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.36
| 1. Piotroski 7.50pt |
| 2. FCF Yield 4.96% |
| 3. FCF Margin 8.00% |
| 4. Debt/Equity 1.07 |
| 5. Debt/Ebitda 1.81 |
| 6. ROIC - WACC (= 10.17)% |
| 7. RoE 30.81% |
| 8. Rev. Trend 98.52% |
| 9. EPS Trend 93.12% |
What is the price of LDOS shares?
Over the past week, the price has changed by +0.64%, over one month by -2.14%, over three months by +0.75% and over the past year by +28.86%.
Is LDOS a buy, sell or hold?
- Strong Buy: 8
- Buy: 2
- Hold: 7
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the LDOS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 218.1 | 17.3% |
| Analysts Target Price | 218.1 | 17.3% |
| ValueRay Target Price | 222.3 | 19.6% |
LDOS Fundamental Data Overview December 23, 2025
P/E Trailing = 17.2437
P/E Forward = 15.015
P/S = 1.3671
P/B = 4.81
P/EG = 2.34
Beta = 0.589
Revenue TTM = 17.33b USD
EBIT TTM = 2.06b USD
EBITDA TTM = 2.35b USD
Long Term Debt = 4.63b USD (from longTermDebt, last quarter)
Short Term Debt = 19.0m USD (from shortTermDebt, last quarter)
Debt = 5.23b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.25b USD (from netDebt column, last quarter)
Enterprise Value = 27.95b USD (23.69b + Debt 5.23b - CCE 974.0m)
Interest Coverage Ratio = 10.18 (Ebit TTM 2.06b / Interest Expense TTM 202.0m)
FCF Yield = 4.96% (FCF TTM 1.39b / Enterprise Value 27.95b)
FCF Margin = 8.00% (FCF TTM 1.39b / Revenue TTM 17.33b)
Net Margin = 8.11% (Net Income TTM 1.41b / Revenue TTM 17.33b)
Gross Margin = 17.61% ((Revenue TTM 17.33b - Cost of Revenue TTM 14.28b) / Revenue TTM)
Gross Margin QoQ = 18.37% (prev 18.39%)
Tobins Q-Ratio = 2.06 (Enterprise Value 27.95b / Total Assets 13.54b)
Interest Expense / Debt = 0.98% (Interest Expense 51.0m / Debt 5.23b)
Taxrate = 23.76% (115.0m / 484.0m)
NOPAT = 1.57b (EBIT 2.06b * (1 - 23.76%))
Current Ratio = 1.62 (Total Current Assets 4.85b / Total Current Liabilities 2.99b)
Debt / Equity = 1.07 (Debt 5.23b / totalStockholderEquity, last quarter 4.91b)
Debt / EBITDA = 1.81 (Net Debt 4.25b / EBITDA 2.35b)
Debt / FCF = 3.07 (Net Debt 4.25b / FCF TTM 1.39b)
Total Stockholder Equity = 4.56b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.38% (Net Income 1.41b / Total Assets 13.54b)
RoE = 30.81% (Net Income TTM 1.41b / Total Stockholder Equity 4.56b)
RoCE = 22.38% (EBIT 2.06b / Capital Employed (Equity 4.56b + L.T.Debt 4.63b))
RoIC = 16.60% (NOPAT 1.57b / Invested Capital 9.45b)
WACC = 6.43% (E(23.69b)/V(28.92b) * Re(7.68%) + D(5.23b)/V(28.92b) * Rd(0.98%) * (1-Tc(0.24)))
Discount Rate = 7.68% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -2.89%
[DCF Debug] Terminal Value 79.31% ; FCFE base≈1.36b ; Y1≈1.46b ; Y5≈1.79b
Fair Price DCF = 244.7 (DCF Value 31.29b / Shares Outstanding 127.9m; 5y FCF grow 8.43% → 3.0% )
EPS Correlation: 93.12 | EPS CAGR: 19.58% | SUE: 1.38 | # QB: 3
Revenue Correlation: 98.52 | Revenue CAGR: 6.81% | SUE: 2.92 | # QB: 1
EPS next Quarter (2026-03-31): EPS=3.00 | Chg30d=+0.006 | Revisions Net=+1 | Analysts=11
EPS next Year (2026-12-31): EPS=12.31 | Chg30d=+0.021 | Revisions Net=+10 | Growth EPS=+4.5% | Growth Revenue=+3.9%
Additional Sources for LDOS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle